Pathology slide review

Confirm what tissue was examined and whether the material can answer the treatment question.

A pathology second opinion may review the written diagnosis, original glass slides, paraffin blocks, stains, and molecular findings. The receiving laboratory must first confirm what material it accepts and how it should be released, packaged, shipped, tracked, and returned.

What can pathology review clarify?

A specialist pathologist may confirm or refine tissue type, grade, margins, biomarkers, or another diagnostic feature. The review can also identify limited material, labeling concerns, or a need for additional stains, molecular tests, or a new biopsy.

Request second opinion Upload reports

Planning overview

Pathology Slide Review and Biopsy Second Opinion

This page helps families understand that a pathology second opinion is a controlled laboratory process, not simply emailing a report. It covers specimen identity, release, slides, blocks, stains, molecular tests, tissue limitations, shipping, digital review, urgent-treatment timing, and the handoff from pathology into multidisciplinary treatment planning.

Best next step

Start with the page section that matches the patient’s current stage: reports if records are ready, cost if a procedure is already advised, or travel support once a hospital direction is clear.

Key guidance

What this page helps you decide

Specimen material

The report, slides, blocks, and molecular results answer different questions

The report records the original interpretation. Slides show selected stained tissue sections, while a paraffin block may allow additional sections or tests if enough tissue remains. Some treatment decisions also depend on immunohistochemistry or molecular results that should be reviewed with the tissue diagnosis.

Ask the receiving pathologist which slides, blocks, stains, and reports are required.

Do not assume every block can be released or that enough tissue remains for more testing.

Include the biopsy site and procedure because tissue from different locations may represent different questions.

Identity and custody

Specimen identity must remain clear from the original laboratory to the reviewer and back

Slides and blocks should carry consistent patient and accession identifiers linked to the report. Families should use the formal release process, keep an inventory, follow packaging instructions, use trackable transport, and clarify whether material must be returned.

Resolve spelling or accession discrepancies before shipping.

Photograph the inventory and retain courier tracking and receipt confirmation.

Never place loose glass slides in ordinary envelopes or remove laboratory labels.

Diagnostic limitations

Small biopsies, decalcified tissue, treatment effect, and exhausted blocks can restrict testing

A sample may not contain enough representative tissue, may have changed after therapy, or may not support every requested biomarker. The pathologist may recommend deeper sections, additional stains, review of another block, correlation with imaging, or repeat biopsy.

Do not promise that all requested molecular tests are technically possible.

Urgent treatment should not be delayed solely for specimen transfer without clinician agreement.

Digital whole-slide images may help in some settings, but acceptance and diagnostic use must be confirmed by the receiving center.

Speak with the patient team

Share the current question before making the next commitment.

Tell Virello Health what has already been diagnosed, which reports are available, and where the patient is in the journey. The team can help identify the appropriate review or coordination step.

Official email: support@virellohealth.com

Let Us Help You

Share the basics and the Virello team will guide you toward the next step.

Prefer email? Write to support@virellohealth.com.

Patient Name

Country

Phone Number

Describe The Current Medical Problem

Conditions

Conditions and patient situations covered

Situations where pathology review may be useful

Rare or unexpected diagnosis

Uncommon tumors, unusual subtypes, pediatric disease, sarcoma, lymphoma, and ambiguous tissue may benefit from specialist pathology expertise.

Treatment depends on subtype or biomarker

Receptor, immunohistochemistry, molecular, cytogenetic, or genomic findings may influence medicine or trial discussions.

Clinical and imaging findings do not match

Discordance may require slide review, another block, additional testing, or repeat biopsy.

Recurrence or new lesion after treatment

The team may need to compare current tissue with the original diagnosis and account for treatment effect.

Procedures

Common treatment pathways to compare

Steps inside a pathology second opinion

Case and material triage

The receiving laboratory confirms the clinical question, specimen site, available reports, slides, blocks, stains, and test history.

Identity and quality check

Identifiers, accession numbers, slide condition, tissue adequacy, and report correspondence are checked before interpretation.

Microscopic and ancillary review

The pathologist examines available material and decides whether deeper sections, stains, molecular tests, or another specimen are needed.

Integrated report and handoff

The result documents agreement, refinement, limitation, or further need and is discussed with the treating team.

Doctor team

Specialists who may need to review the case

Subspecialty pathologist

Reviews tissue from the relevant organ system or disease category and documents limitations.

Original laboratory

Maintains the source specimen, authorizes release, identifies material, and records what leaves and returns.

Treating oncologist or surgeon

Interprets pathology with imaging, examination, stage, operability, symptoms, and treatment goals.

Molecular laboratory or genetic specialist

May be needed when treatment questions depend on validated molecular, cytogenetic, or hereditary testing.

Hospital selection

How to compare hospitals beyond the headline package

Subspecialty pathology

Confirm experience with the organ, tumor type, hematologic disease, pediatric case, or rare diagnosis.

Ask who signs the review.

Ancillary testing

Check availability and validation for stains, flow cytometry, cytogenetics, molecular tests, and whole-slide imaging.

Material may be limited.

Specimen logistics

The laboratory should provide exact acceptance, packaging, courier, customs, receipt, storage, and return instructions.

Confirm before release.

Tumor-board integration

Pathology should connect with imaging and treatment specialists when results affect sequence or eligibility.

Complex cases need context.

Reports

Pathology review preparation list

Reports should be organized before a second opinion, quote, or hospital shortlist is requested.

Documents that should travel with the specimen

Original pathology report

Include final diagnosis, gross and microscopic description when available, comments, specimen site, accession, and signatory.

Procedure and clinical history

Provide biopsy method, surgery note, prior cancer, treatment exposure, symptoms, and the exact diagnostic question.

Ancillary results

Include immunohistochemistry, flow, cytogenetics, molecular, receptor, and biomarker reports already performed.

Imaging and stage context

Relevant scans help determine whether tissue findings fit lesion location, extent, recurrence, or another process.

1 Complete pathology report with patient and accession identifiers
2 Biopsy or surgery date, exact specimen site, and procedure note
3 Requested original slides and paraffin blocks
4 Immunohistochemistry stain list and result sheets
5 Molecular, cytogenetic, or biomarker reports when performed
6 Relevant imaging, stage information, and prior treatment history
7 Original-laboratory release approval and receiving-laboratory instructions
8 Tracked packaging, courier, customs, receipt, and return plan

Cost planning

Factors that can change the estimate

Number and type of specimens

Several blocks, slides, sites, or historical cases require more handling and review.

Use an exact inventory.

Additional stains or tests

Ancillary studies may add laboratory cost and use limited tissue.

Ask before authorization.

Courier and customs

Special packaging, tracking, customs documents, insurance, and return shipping may apply.

Physical material is irreplaceable.

Repeat biopsy

Inadequate or exhausted tissue may require another procedure and associated hospital care.

Not guaranteed to be necessary or feasible.

Compare treatment costs Request estimate

Patient journey

From first reports to follow-up at home

Define the pathology question

State whether review concerns diagnosis, subtype, grade, margins, biomarkers, recurrence, or treatment eligibility.

Confirm receiving-laboratory requirements

Obtain written instructions for reports, slides, blocks, digital files, packaging, and return.

Request formal release and inventory

Work with the original laboratory to identify and document every item.

Track receipt and review

Confirm safe arrival, material adequacy, additional-test authorization, and expected communication route.

Discuss the result with the treating team

Connect pathology with imaging, stage, patient condition, and treatment options.

Multidisciplinary review

Travel planning

Practical support to connect with the medical plan

Review may occur before the patient travels

Physical material and reports can sometimes be assessed before the patient books treatment travel.

Do not hand-carry without confirmation

Laboratory release, airline, border, customs, and receiving-center requirements should be checked in advance.

Protect treatment timing

The treating team should decide whether the patient can safely wait for review or needs immediate local treatment.

Safety questions

Questions to ask before committing

Are identifiers consistent?

Patient name, date of birth, accession, specimen site, and report should correspond across every item.

Is tissue sufficient?

Ask whether enough representative material remains for review and any proposed ancillary tests.

Could transport damage the specimen?

Use approved packaging and tracking; clarify temperature, handling, and breakage precautions.

Who will act on a changed diagnosis?

Confirm how an important discrepancy reaches the patient and treating team promptly.

Recovery

Follow-up and return-home planning

Keep both reports

Preserve the original and second-opinion reports with the complete treatment record.

Track returned material

Confirm whether slides or blocks return to the source laboratory and document receipt.

Update the local clinician

Share any diagnosis or biomarker change with the home-country team responsible for continuing care.

Possible pathology-review outcomes

Diagnosis supported

The reviewing pathologist may agree and clarify grade, subtype, margins, or treatment-relevant features.

Diagnosis refined

Additional review may narrow or alter classification, prompting discussion with the treating team.

More tissue or testing needed

The material may be insufficient, nonrepresentative, exhausted, technically limited, or require another specimen.

Questions

Common questions

Is the written pathology report enough for a second opinion?

It can support initial triage, but a true pathology reinterpretation may require original slides, blocks, digital slides, or additional laboratory material depending on the question.

What is the difference between a slide and a paraffin block?

A slide contains a thin stained tissue section for microscopic review. A paraffin block contains preserved tissue from which additional sections or some tests may be prepared if sufficient material remains.

Can I personally collect the specimen material?

The original laboratory determines its release process. Use documented authorization, an exact inventory, protective packaging, and the receiving laboratory’s instructions.

Can blocks or slides be damaged during shipping?

Yes. Glass can break and material can be lost or exposed to unsuitable conditions. Use laboratory-approved containers, tracking, and clear sender and recipient contacts.

Will every second review produce a definitive diagnosis?

No. Small, crushed, treated, decalcified, poorly preserved, or nonrepresentative tissue may remain uncertain and may require another block, test, or biopsy.

Can pathology review change cancer treatment?

It can when diagnosis, subtype, grade, margins, receptors, biomarkers, or molecular findings differ, but the treating team must interpret the result with imaging and clinical context.

Should treatment wait until the slides reach India?

Only the treating clinicians should decide whether waiting is clinically acceptable. Urgent treatment or unstable disease should not be delayed by routine logistics.

Are digital pathology images accepted everywhere?

No. Whole-slide imaging capabilities, validation, file formats, platform access, and legal acceptance vary by laboratory. Confirm before relying on a digital-only review.

Clinical and technical references

Sources used for this planning guide

Editorially reviewed in July 2026 using National Cancer Institute pathology guidance. Specimen release, testing, transport, and acceptance must be confirmed with both laboratories.

Surgical Pathology Reports, National Cancer Institute

Explains pathology reports, tissue examination, second opinions, slides, paraffin blocks, and treatment planning.

Uniform Labeling of Blocks and Slides in Surgical Pathology, College of American Pathologists

Provides historical patient-safety context for clear specimen identification and accession labeling.